Find out more about the technologies we have available for licensing
MRC Technology adds value to cutting edge scientific discoveries through strategic patent protection, creative licensing of intellectual property or partnered research with MRC Units and Institutes.
We offer opportunities for collaborations, partnerships, and exclusive or non-exclusive licenses in
- Platform technologies
- Drug targets
- Small molecule drug and
therapeutic antibody candidates
We have an excellent track record of managing partnerships and collaborations, from funded studentships and post-docs through to formation of industry/academic collaborative groups. One such partnership was described as the model for how industrial-academic collaborations should work by GlaxoSmithKline.
The antibody for Avastin was humanised using CDR grafting technology licensed to Genentech by MRC